You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alpelisib

Showing 1 - 25 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Characterize and Manage Hyperglycemia in Patients Initiating

Recruiting
  • Metastatic Breast Cancer
  • Alpelisib
  • FreeStyle Libre 2 Continuous Glucose Monitor
  • Saint Louis Park, Minnesota
    HealthPartners Cancer Research Center
Oct 16, 2023

Lymphatic Malformations Trial (Alpelisib, Placebo)

Not yet recruiting
  • Lymphatic Malformations
  • Alpelisib
  • Placebo
  • (no location specified)
Jul 4, 2023

Lymphangioma Trial in Albuquerque (Alpelisib)

Available
  • Lymphangioma
  • Alpelisib
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)

Recruiting
  • Insulin Resistance
  • +2 more
  • Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 3, 2023

Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Thalassery, Kerala, India
    Novartis Investigative Site
Nov 21, 2022

PIK3CA-Related Overgrowth Spectrum (PROS) Trial in Worldwide (alpelisib)

Available
  • PIK3CA-Related Overgrowth Spectrum (PROS)
  • alpelisib
  • (no location specified)
Sep 9, 2022

Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 30, 2023

Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Haifa, Israel
    Rambam Health Care Campus
Feb 22, 2023

Breast Cancer Trial in United States (Benralizumab, fulvestrant or AIs) and PI3K inhibition (alpelisib))

Recruiting
  • Breast Cancer
  • Benralizumab
  • fulvestrant or AIs) and PI3K inhibition (alpelisib)
  • Stanford, California
  • +8 more
Aug 1, 2023

Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast

Completed
  • HR+/HER2- Advanced or Metastatic Breast Cancer
    • Dublin, Ireland
      Novartis Pharmaceuticals
    May 2, 2023

    Healthy Volunteers Trial in Belfast (Treatment A, Treatment B, Treatment C)

    Recruiting
    • Healthy Volunteers
    • Treatment A
    • +2 more
    • Belfast, Northern Ireland, United Kingdom
      Novartis Investigative Site
    Jun 29, 2022

    HR+, HER2-, Advanced Breast Cancer Trial (alpelisib)

    Available
    • HR+, HER2-, Advanced Breast Cancer
    • alpelisib
    • (no location specified)
    Jul 5, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +3 more
    • Alpelisib
    • +7 more
    • (no location specified)
    Jul 28, 2023

    Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP) Trial in Dijon (Alpelisib (BYL719), Matching , Optional

    Recruiting
    • Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
    • Alpelisib (BYL719)
    • +2 more
    • Dijon, France
      Chu Dijon Bourgogne
    Nov 29, 2022

    Advanced Breast Cancer Trial in Orebro (Alpelisib, fulvestrant)

    Terminated
    • Advanced Breast Cancer
    • Orebro, Sweden
    • +1 more
    Nov 21, 2022

    A NIS of Alpelisib in Combination With Fulvestrant in

    Not yet recruiting
    • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
    • Alpelisib
    • Fulvestrant
    • (no location specified)
    Aug 9, 2022

    Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

    Not yet recruiting
    • Breast Cancer Stage IV
    • Nice, France
    • +1 more
    Nov 14, 2022

    Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

    Not yet recruiting
    • Solid Tumors, Adult
    • +7 more
    • Alpelisib
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Jul 21, 2022

    Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

    Recruiting
    • Advanced Breast Carcinoma
    • +17 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma Trial in Houston (L-NMMA)

    Recruiting
    • HER2-negative Breast Cancer
    • +3 more
    • Houston, Texas
      Houston Methodist Neal Cancer Center
    Jan 12, 2023

    Among Healthcare Professionals Treating Metastatic Breast Cancer

    Recruiting
    • Breast Cancer
    • Piqray Prescriber's/HCP guide for hyperglycemia
    • Basel, Switzerland
      Novartis Investigative Site
    Oct 11, 2022

    Tolerability Outcomes of Alpelisib in Real-world

    Recruiting
    • Breast Cancer
    • alpelisib plus fulvestrant
    • Mumbai, Maharashtra, India
    • +3 more
    Jun 8, 2022

    HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Trial (Evexomostat)

    Not yet recruiting
    • HR+/HER2-negative Breast Cancer
    • Metastatic Breast Cancer
    • (no location specified)
    Jul 7, 2022

    A Post Marketing Surveillance on Piqray in Korea

    Recruiting
    • Breast Cancer
    • Piqray
    • Deogyang Gu Goyang Si, Gyeonggi Do, Korea, Republic of
    • +4 more
    Jan 16, 2023

    Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +3 more
    • (no location specified)
    Aug 18, 2022